The maturation of neuroscience, insights into fundamental mechanisms, and applications of molecular genetics and cellular biology have fueled an unprecedented opportunity to carry out population-based clinical research aimed at identifying key risk factors and therapeutic interventions to relieve the burden of neurologic disease. The reporting of population-based clinical research, particularly of randomized controlled trials (RCTs), represents the final common pathway for translational research and the accrued knowledge base for our health and public policies. The Archives of Neurology editorial board is mindful of this importance and places high priority on the solicitation and publication of excellent reports of RCTs and other population-based neurologic research.
Shoulson I, Rosenberg RN. Reporting of Randomized Clinical Trials and Other Population-Based Research: A Priority of Archives of Neurology. Arch Neurol. 2004;61(1):20–21. doi:10.1001/archneur.61.1.20
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: